Get started
Author

Kai Yamasaki

Observed names: K. Yamasaki, Yamasaki, Kai
ORCID: 0000-0002-5701-8813
Observed ORCID: 0000-0002-5701-8813
OpenAlex ID: A5043928170
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
2016 · Hideyuki Arita, Kai Yamasaki, et al. · Acta Neuropathologica Communications · 252
PDF
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors
2018 · on behalf of the Japan Pediatric Molecular Neuro-Oncology Group (JPMNG), Kohei Fukuoka, et al. · Acta Neuropathologica Communications · 132
PDF
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
2021 · Kenji Fujimoto, Hideyuki Arita, et al. · Acta Neuropathologica · 104
Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas
2017 · Shintaro Fukushima, Satoshi Yamashita, et al. · Acta Neuropathologica · 101
The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors
2021 · Hideo Nakamura, Hirokazu Takami, et al. · Neuro-Oncology · 76
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations
2020 · Hideyuki Arita, Yuko Matsushita, et al. · Acta Neuropathologica Communications · 63
Spinal cord astroblastoma with an EWSR1‐BEND2 fusion classified as a high‐grade neuroepithelial tumour with MN1 alteration
2019 · K. Yamasaki, Y. Nakano, et al. · Neuropathology and Applied Neurobiology · 50
Phase I Study of Bevacizumab Plus Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors
2013 · K. Okada, K. Yamasaki, et al. · Japanese Journal of Clinical Oncology · 33
Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance
2019 · H. Takami, S. Fukushima, et al. · Neuropathology and Applied Neurobiology · 31
Pediatric thalamic glioma with H3F3A K27M mutation, which was detected before and after malignant transformation: a case report
2016 · Kenichi Ishibashi, Takeshi Inoue, et al. · Child s Nervous System · 30
Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation
2019 · Yoshiko Nakano, Daiichiro Hasegawa, et al. · Modern Pathology · 29
Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: a retrospective study by the Japan Children’s Cancer Group
2020 · Kai Yamasaki, Chikako Kiyotani, et al. · Journal of Neurosurgery Pediatrics · 28
Identification of a novel KLC1–ROS1 fusion in a case of pediatric low-grade localized glioma
2018 · Yoshiko Nakano, Arata Tomiyama, et al. · Brain Tumor Pathology · 22
Strategy to minimize radiation burden in infants and high‐risk medulloblastoma using intrathecal methotrexate and high‐dose chemotherapy: A prospective registry study in Japan
2019 · Kai Yamasaki, Keiko Okada, et al. · Pediatric Blood & Cancer · 18
PDF
Sorafenib treatment in children with relapsed and refractory neuroblastoma: an experience of four cases
2016 · Keiko Okada, Yoshiko Nakano, et al. · Cancer Medicine · 18
PDF
Double‐conditioning regimen consisting of high‐dose thiotepa and melphalan with autologous stem cell rescue for high‐risk pediatric solid tumors: A second report
2019 · Keiko Okada, Kai Yamasaki, et al. · Pediatric Blood & Cancer · 14
Low tumor cell content predicts favorable prognosis in germinoma patients
2021 · Hirokazu Takami, Kaishi Satomi, et al. · Neuro-Oncology Advances · 12
A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations
2019 · Yoshiko Nakano, Kai Yamasaki, et al. · Brain Tumor Pathology · 12
Histological and genetic analysis of anaplastic pleomorphic xanthoastrocytoma suspected of malignant progression over a 12‐year clinical course
2019 · Hiroko Fukushima, Yoshiko Nakano, et al. · Pathology International · 10
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study
2023 · Kohei Fukuoka, Jun Kurihara, et al. · Acta Neuropathologica Communications · 9
PDF
Outcomes of Local Radiation and Intensified Combined Intrathecal Methotrexate and High-dose Chemotherapy for Intracranial Germ Cell Tumors
2020 · Kai Yamasaki, Keiko Okada, et al. · Journal of Pediatric Hematology/Oncology · 9
High Grade Gliomas
2012 · A. Leonard, J. Wolff, et al. · Neuro-Oncology · 9
PDF
Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
2021 · Kazuki Tanimura, Kai Yamasaki, et al. · Case Reports in Oncology · 8
Genome‐wide DNA methylation profiling shows molecular heterogeneity of anaplastic pleomorphic xanthoastrocytoma
2019 · Taishi Nakamura, Kohei Fukuoka, et al. · Cancer Science · 8
PDF
Acute Myeloid Leukemia With RBM15-MKL1 Presenting as Severe Hepatic Failure
2017 · Yoshiko Nakano, Kai Yamasaki, et al. · Global Pediatric Health · 8
PDF
Works count: 106
Citation count: 1,161
H-index: 15
I10-index: 19
Year
Topic
Type